PSEN1 and melanoma: Moreover, since AD has been associated with aberrant PS-1 function and/or expression [12], our finding that PS-1 levels were lower in patients with certain types of melanoma also provides a possible explanation as to why the incidence of AD is lower in patients with melanoma [9,10].